Zhejiang Ausun Pharmaceutical , Ltd. Inventory

Zhejiang Ausun Pharmaceutical , Ltd. (603229.SS) currently reports a inventory of $370M as of June 2026. That compares with $400M in the prior-year period — down 8.0% year over year. Use the charts on this page to explore Zhejiang Ausun Pharmaceutical , Ltd.'s inventory history and peer comparisons.

Zhejiang Ausun Pharmaceutical , Ltd.'s inventory decreased from $400M to $370M — a 8.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zhejiang Ausun Pharmaceutical , Ltd. reported $370M in inventory as of June 2026. That compares with $400M in the prior-year period — down 8.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $370M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zhejiang Ausun Pharmaceutical , Ltd., and consider following 603229.SS for alerts when major investors trade the stock.

Zhejiang Ausun Pharmaceutical , Ltd. is classified in the Healthcare sector. On inventory, it currently shows $370M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 603229.SS with unrelated industries.